Document Type
Article
Publication Date
11-1-1991
Abstract
Glucocorticoids (GC) modulate immune function in a number of ways, including suppression of T cell proliferation and other IL-2-mediated T cell functions. These inhibitory effects are similar to those induced by transforming growth factor-beta 1 (TGF-beta 1), a cytokine with potent T cell inhibiting activities. We examined the hypothesis that GC effects may be at least partially achieved through modulation of the expression of the TGF-beta 1 gene in activated T cells. Normal T cells were cultured with or without purified phytohemagglutinin (PHA-p) and 4 beta-phorbol 12-myristate 13-acetate (PMA) in the presence or absence of the synthetic GC, dexamethasone (100-200 micrograms/ml). The production of latent and active forms of TGF beta by these cells were analyzed by immunoblotting and bioassays. The steady-state levels of TGF-beta 1 mRNA were analyzed in total RNA from these cells by Northern hybridizations using a human TGF-beta 1 cDNA. The results showed that dexamethasone caused an increase in TGF beta production and a dose-dependent two to fourfold increase in TGF-beta 1 mRNA in activated as well as in unstimulated T cells, 1 h after exposure of the cultures to the steroid. The increase in TGF-beta 1 mRNA levels by dexamethasone was further potentiated two to threefold by cycloheximide, suggesting that the steroid effect may be due to inhibition of the synthesis of proteins that decrease TGF-beta 1 gene transcription or the stability of its transcripts. Finally, in vitro nuclear transcription studies indicated the dexamethasone effects on TGF-beta 1 gene expression to be largely transcriptional.
Recommended Citation
AyanlarBatuman, O.; Ferrero, A. P.; Diaz, Arturo; and Jimenez, Sergio A., "Regulation of transforming growth factor-beta 1 gene expression by glucocorticoids in normal human T lymphocytes." (1991). Department of Medicine Faculty Papers. Paper 193.
https://jdc.jefferson.edu/medfp/193
PubMed ID
1939646
Comments
This article has been peer reviewed. It is the author’s final published version in Journal of Clinical Investigation
Volume 88, Issue 5, November 1991, Pages 1574-80.
The published version is available at DOI: 10.1172/JCI115469. Copyright © The American Society for Clinical Investigation, Inc.